周二盘中，德国生物科技公司BioNTech SE（BNTX）股价大涨5.66%，引发市场关注。此次上涨主要受到全球疫情形势变化和监管政策调整的影响。
根据世界卫生组织最新公布的数据，西非、中美洲和加勒比地区、东欧、西南欧和西亚部分国家的新冠疫情呈上升趋势。这一消息引发了市场对疫苗需求可能增加的预期，推动了包括BioNTech在内的疫苗股普遍上涨。同时，美国食品和药物管理局（FDA）宣布了新的COVID-19疫苗增强剂指南，进一步刺激了相关股票的表现。
FDA的最新指南计划要求对65岁以下健康成年人进行新的临床试验，以批准年度COVID-19增强剂注射。尽管这可能会限制今年秋季增强剂的使用范围，主要面向65岁以上老年人和高风险人群，但FDA官员预计仍有1亿至2亿美国人有资格每年接种疫苗。这一消息表明，疫苗市场仍有较大需求，为BioNTech等疫苗生产商提供了持续的业务机会。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.